Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.8.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2018
Dec. 31, 2017
Investment in real estate:    
Land $ 52,301 $ 42,701
Building 436,185 384,338
Site improvements 5,590 4,808
Tenant improvements 9,201 8,010
Acquired lease intangible assets 34,034 31,650
Real Estate Investment Property, at Cost, Total 537,311 471,507
Less: accumulated depreciation and amortization (17,420) (13,594)
Investment in real estate, net 519,891 457,913
Cash and cash equivalents 3,351 5,109
Restricted cash 4,050 2,005
Tenant receivables 1,253 704
Escrow deposits 2,508 1,638
Deferred assets 5,171 3,993
Deferred financing costs, net 3,105 2,750
Other assets 527 459
Total assets 539,856 474,571
Liabilities:    
Revolving credit facility 229,150 164,900
Notes payable, net of unamortized discount of $898 and $930 at March 31, 2018 and December 31, 2017, respectively 38,577 38,545
Accounts payable and accrued expenses 4,125 2,020
Dividends payable 5,826 5,638
Security deposits and other 4,912 2,128
Due to related parties, net 1,035 1,036
Acquired lease intangible liability, net 1,488 1,291
Total liabilities 285,113 215,558
Stockholders' equity:    
Preferred stock, $0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at March 31, 2018 and December 31, 2017 (liquidation preference of $77,625 at March 31, 2018 and December 31, 2017) 74,959 74,959
Common stock, $0.001 par value, 500,000 shares authorized; 21,631 shares issued and outstanding at March 31, 2018 and December 31, 2017 22 22
Additional paid-in capital 205,788 205,788
Accumulated deficit (38,349) (34,434)
Total Global Medical REIT Inc. stockholders' equity 242,420 246,335
Noncontrolling interest 12,323 12,678
Total stockholders’ equity 254,743 259,013
Total liabilities and stockholders' equity $ 539,856 $ 474,571